BLVRB
Summary: The final step in heme metabolism in mammals is catalyzed by the cytosolic biliverdin reductase enzymes A and B (EC 1.3.1.24).[supplied by OMIM, Jul 2009].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| biliverdin reductase B | MIM:600941 | Ensembl:ENSG00000090013 | HGNC:HGNC:1063 | PA25374 | 19q13.2 |
GO terms in BLVRB
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IDA | GO:0005654 | nucleoplasm |
| CC | IDA | GO:0005829 | cytosol |
| CC | TAS | GO:0005829 | cytosol |
| CC | IDA | GO:0005886 | plasma membrane |
| CC | IEA | GO:0043195 | terminal bouton |
| CC | HDA | GO:0070062 | extracellular exosome |
| BP | IDA | GO:0042167 | heme catabolic process |
| BP | TAS | GO:0042167 | heme catabolic process |
| BP | IEA | GO:0055114 | oxidation-reduction process |
| MF | IDA | GO:0004074 | biliverdin reductase activity |
| MF | TAS | GO:0004074 | biliverdin reductase activity |
| MF | IDA | GO:0042602 | riboflavin reductase (NADPH) activity |
Gene expression in normal tissue: BLVRB
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in BLVRB
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| wikipathways | WP2882 | Nuclear Receptors Meta-Pathway |
| wikipathways | WP2884 | NRF2 pathway |
| kegg | hsa00740 | Riboflavin metabolism - Homo sapiens (human) |
| kegg | hsa00860 | Porphyrin and chlorophyll metabolism - Homo sapiens (human) |
| pharmgkb | PA165980834 | Methylene Blue Pathway, Pharmacodynamics |
| humancyc | PWY-5874 | heme degradation |
| biocarta | il10pathway | il-10 anti-inflammatory signaling pathway |
| reactome | R-HSA-1430728 | Metabolism |
| reactome | R-HSA-189445 | Metabolism of porphyrins |
| reactome | R-HSA-189483 | Heme degradation |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in BLVRB

